IMNM
ImmunomeยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
IMNM Profile
Immunome, Inc.
A biopharmaceutical company that develops antibody therapeutics for the treatment of cancer and infectious diseases
18702 N. Creek Parkway, Suite 100 Bothell, WA 98011
--
Immunome, Inc., was incorporated as a Pennsylvania corporation on March 2, 2006 and converted to a Delaware corporation on December 2, 2015. The Company is a biopharmaceutical company that utilizes its proprietary Human Memory B Cell Platform to discover and develop first-in-class antibody therapies designed to transform the way diseases are currently treated. The company's patent discovery platform identifies new therapeutic antibodies and their targets from patients who have learned to beat the disease by leveraging a highly educated component of the immune system, memory B cells.
